India caps essential drug prices
This article was originally published in Scrip
Executive Summary
India has issued a new order that will cap the prices of over 650 formulations across 27 therapeutic segments specified in the country's national list of essential medicines (NLEM) 2011, as per a previously announced national pharmaceutical pricing policy.